医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
CUE · Cue Biopharma, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Cue Biopharma, Inc.（CUE）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $2.4M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-14。
买入 Bought—
卖出 Sold$2.4M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-12 | Ray Sumita Chief Legal Compliance Officer, Other | 卖出 Sell | 1,844 | $28.05 | $52K | SEC |
| 2026-10-12 | Lin Shao-Lee Chief Executive Officer, Director | 卖出 Sell | 11,087 | $27.55 | $305K | SEC |
| 2026-10-12 | Meluzio Michael Vincent VP, Prin. Accounting Officer | 卖出 Sell | 1,144 | $28.05 | $32K | SEC |
| 2026-08-13 | Ray Sumita Chief Legal Compliance Officer, Other | 卖出 Sell | 8,829 | $30.09 | $266K | SEC |
| 2026-08-13 | Meluzio Michael Vincent VP, Prin. Accounting Officer | 卖出 Sell | 5,628 | $30.09 | $169K | SEC |
| 2026-08-12 | Lin Shao-Lee Chief Executive Officer, Director | 卖出 Sell | 58,258 | $27.58 | $1.6M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-12 | Lin Shao-Lee Officer, Director | 11,087 | $305K | |
| 2026-10-12 | Ray Sumita Officer, CORPORATE SECRETARY | 1,844 | $52K | |
| 2026-08-12 | Lin Shao-Lee Officer, Director | 58,258 | $1.6M | |
| 2026-08-13 | Ray Sumita Officer, CORPORATE SECRETARY | 8,829 | $266K |
内部人 Insiders
Ray Sumita、Lin Shao-Lee、Meluzio Michael Vincent